Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infection
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infection
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume 19, Issue 2, Pages e126-e133
Publisher
Wiley
Online
2011-09-14
DOI
10.1111/j.1365-2893.2011.01516.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus
- (2011) Jean-Michel Pawlotsky HEPATOLOGY
- PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division
- (2010) Claudia von Montfort et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy
- (2010) C. N. Hayes et al. GUT
- Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
- (2010) Kazuaki Chayama et al. HEPATOLOGY RESEARCH
- Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing
- (2010) Wendy S.C. Cheng et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma: a global view
- (2010) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- PAI-1 and kidney fibrosis
- (2009) Li-Jun Ma Frontiers in Bioscience-Landmark
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Reproducibility of serum cytokines and growth factors
- (2008) Yian Gu et al. CYTOKINE
- Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads
- (2008) Hitomi Sezaki et al. DIGESTIVE DISEASES AND SCIENCES
- Diagnosis and Quantitation of Fibrosis
- (2008) Diarmuid S. Manning et al. GASTROENTEROLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search